HOPU Investments is a Beijing-based private equity firm that provides institutional capital through direct private-company investments. Its U.S. activity includes later-stage venture financing for life sciences and pharmaceutical companies, with exposure to biotechnology, life sciences and pharmaceuticals. The firm is most relevant for founders seeking Asia-linked private-market backing for later-stage healthcare and drug-development opportunities.